Key Takeaways Industry/Company - **Company**: The Clorox Company (NYSE:CLX) - **Industry**: Consumer Goods, Household Products, Cleaning & Disinfecting Core Points and Arguments - **COVID-19 Impact**: The company has seen significant growth in the Cleaning segment due to increased demand during the pandemic. However, there has been volatility post-COVID with demand dropping off and outsized commodity pressure. - **Growth Opportunities**: - **Global Cleaning & Disinfecting**: Expansion of wipes business internationally, out-of-home opportunities, and U.S. retail growth. - **Household Essentials**: Increased grill ownership, pet adoption rates, and remote work trends. - **Topline Guidance**: 2% to 6% decline in revenue for the year, driven by commodity inflation and supply chain challenges. - **Innovation**: Strong focus on innovation, particularly platform-driven initiatives, to drive top-line growth. - **Digital Transformation**: $500 million investment over five years to increase digital capabilities in supply chain and operations. - **Gross Margin Compression**: Record levels of year-over-year compression due to unprecedented commodity inflation. - **Pricing Strategy**: Implemented pricing on 70% of the portfolio to offset cost increases, with plans to continue pricing in the back half of the year. - **Cost Savings**: Aggressive cost savings initiatives to offset inflation and improve profitability. - **E-commerce Growth**: Expectation of continued growth in e-commerce and club channels. Other Important Points - **Supply Chain**: Improved supply chain capabilities to address pandemic-related disruptions and meet demand. - **Ad Spend**: Expected to remain at 10% of sales, focusing on improving return on ad spend. - **Productivity**: Continued focus on productivity improvements through disciplined cost management and technology investments. - **ESG**: Focus on sustainability and reducing packaging content as part of the ESG agenda.

Summary of The Clorox Company Q1 2022 Earnings Conference Call Company Overview - **Company**: The Clorox Company (NYSE: CLX) - **Date of Call**: November 1, 2021 - **Participants**: - Linda Rendle – Chief Executive Officer - Kevin Jacobsen – Chief Financial Officer - Lisah Burhan – Vice President, Investor Relations Key Industry Insights - **Demand Trends**: Stronger than anticipated demand across the portfolio, driven by consumer behavior and successful merchandising efforts, particularly during back-to-school promotions [7][11] - **Impact of COVID-19**: The Delta variant did not significantly dampen demand; instead, consumer mobility remained strong, leading to increased health and wellness habits [11][12] - **Pricing Strategy**: Pricing has been implemented on 70% of the portfolio due to rising costs, with expectations of further price increases if necessary [13][16] Financial Performance - **Q1 Performance**: The company reported better-than-expected results, with a shift in consumer demand positively impacting sales [10][28] - **Gross Margin Outlook**: Anticipated sequential improvement in gross margins throughout the fiscal year, with expectations to return to low 40s by Q4 [22][25] - **Cost Inputs**: Revised expectations for cost inputs from $300 million to $350 million, primarily due to resin and transportation costs [22][23] Strategic Initiatives - **Cost Management**: The company is actively addressing inflationary pressures through pricing and cost reduction initiatives [7][8] - **Investment in Innovation**: Continued investment in innovation and advertising to strengthen competitive advantages and support long-term growth [8][39] - **Supply Chain Resilience**: Increased reliance on third-party manufacturers during the pandemic, with plans to revert to self-manufacturing as demand stabilizes [60][61] Risks and Considerations - **Market Volatility**: The company remains cautious about external factors such as the pandemic and cold/flu season, which could impact sales and margins [30][48] - **Elasticity of Demand**: Improved demand elasticity observed, with consumers favoring branded products during the pandemic [75] Additional Insights - **Cash Flow**: Cash flow for the quarter was significantly lower at $41 million, down 89%, attributed to higher inventory levels and timing of receivables [66][67] - **Inventory Management**: The company is working to manage elevated inventory levels while ensuring supply across core brands and innovations [41][68] - **Long-term Sales Growth**: The company expects to return to long-term sales growth of 3% to 5% in the back half of the fiscal year [19][30] This summary encapsulates the key points discussed during The Clorox Company's Q1 2022 earnings conference call, highlighting the company's performance, strategic initiatives, and market outlook.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☑ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2021. OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 1-07151 THE CLOROX COMPANY (Exact name of registrant as specified in its charter) Delaware 31-0595760 (State or other jurisdic ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 __________________ FORM 10-K __________________ ☑ Annual report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for the fiscal year ended June 30, 2021 OR ☐ Transition report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for the transition period from __________to__________. Commission file number: 1-07151 THE CLOROX COMPANY (Exact name of registrant as specified in its c ...

The Clorox Company (NYSE:CLX) Q4 2021 Earnings Conference Call August 3, 2021 1:30 PM ET Company Participants Lisah Burhan - Vice President, Investor Relations Linda Rendle - Chief Executive Officer Kevin Jacobsen - Chief Financial Officer Conference Call Participants Dara Mohsenian - Morgan Stanley Peter Grom - UBS Wendy Nicholson - Citigroup Christopher Carey - Wells Fargo Securities Jason English - Goldman Sachs Kevin Grundy - Jefferies Group LLC Lauren Lieberman - Barclays Investment Bank Stephen Powers ...

The Clorox Company (NYSE:CLX) dbAccess Global Consumer Virtual Conference June 9, 2021 12:00 PM ET Company Participants Linda Rendle – Chief Executive Officer Kevin Jacobsen – Executive Vice President and Chief Financial Officer Conference Call Participants Steve Powers – Deutsche Bank Steve Powers Good afternoon and good evening, everybody. I’m Steve Powers, the Head of Deutsche Bank's U.S. Consumer Goods Research. I’m very excited today to welcome The Clorox Company back to our conference. Joining us toda ...

The Clorox Company (NYSE:CLX) 37th Annual Bernstein Strategic Decisions Virtual Conference June 2, 2021 1:30 PM ET Company Participants Kevin Jacobsen - EVP & CFO Conference Call Participants Callum Elliott - Bernstein Callum Elliott Hi, good afternoon, everybody. I hope you enjoyed the lunch break and the analyst test [OBS] session. My name is Callum Elliott, and I'm Bernstein's new U.S. HPP and beverages analyst. And I'm delighted to be joined this afternoon by Kevin Jacobsen, who's the CFO of Clorox. So ...

The Clorox Company (NYSE:CLX) RBC Capital Markets Global Consumer and Retail Virtual Conference June 2, 2021 11:20 AM ET Company Participants Linda Rendle - CEO Conference Call Participants Nik Modi - RBC Capital Markets Nik Modi I am tea, beverage, packaged food and tobacco analyst, and I'm joined by Clorox CEO, Linda Rendle. Over the last 14 months, Clorox has seen unprecedented demand brought on by the pandemic and has worked tirelessly to provide life-saving and essential products for health care worker ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q 1 (Mark One) ☑ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2021. OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 1-07151 _________________________ THE CLOROX COMPANY (Exact name of registrant as specified in its charter) Delaware 31-0595760 ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q 1 (Mark One) ☑ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended December 31, 2020. OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 1-07151 _________________________ THE CLOROX COMPANY (Exact name of registrant as specified in its charter) Delaware 31-05957 ...